Grifols (GIFLF) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2020)

Grifols (GIFLF) EPS (Weighted Average and Diluted) (QoQ) (2010 - 2020) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 66.32%
Mar 31, 2019 63.43%
Jun 30, 2018 663.44%
Mar 31, 2018 69.04%
Jun 30, 2017 997.59%
Sep 30, 2016 49.54%
Jun 30, 2016 874,728.50%
Mar 31, 2016 -69.64%
Dec 31, 2015 -99.93%
Sep 30, 2015 6,783,832.23%
Jun 30, 2015 -93.91%
Sep 30, 2013 -37.28%
Jun 30, 2013 -49.56%
Mar 31, 2013 121.19%
Dec 31, 2012 38.42%
Sep 30, 2012 -34.92%
Jun 30, 2012 -49.90%
Mar 31, 2012 729.34%
Dec 31, 2011 -70.12%
Sep 30, 2011 185.29%